D.E. Shaw & Co’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-238,233
| Closed | -$976K | – | 6022 |
|
|
2022
Q1 | $976K | Buy |
+238,233
| New | +$864K | ﹤0.01% | 3938 |
|
|
2021
Q1 | – | Sell |
-68,395
| Closed | -$273K | – | 4631 |
|
|
2020
Q4 | $273K | Buy |
68,395
+55,780
| +442% | +$180K | ﹤0.01% | 3635 |
|
|
2020
Q3 | $34K | Sell |
12,615
-45,065
| -78% | -$125K | ﹤0.01% | 3757 |
|
|
2020
Q2 | $158K | Buy |
57,680
+16,566
| +40% | +$46.2K | ﹤0.01% | 3830 |
|
|
2020
Q1 | $97K | Buy |
41,114
+5,147
| +14% | +$17.5K | ﹤0.01% | 3784 |
|
|
2019
Q4 | $169K | Buy |
+35,967
| New | +$147K | ﹤0.01% | 3835 |
|
|
2018
Q3 | – | Sell |
-30,211
| Closed | -$78K | – | 4060 |
|
|
2018
Q2 | $78K | Buy |
+30,211
| New | +$75.2K | ﹤0.01% | 3631 |
|
|
2017
Q2 | – | Sell |
-197,653
| Closed | -$561K | – | 3605 |
|
|
2017
Q1 | $561K | Sell |
197,653
-137,564
| -41% | -$331K | ﹤0.01% | 2676 |
|
|
2016
Q4 | $781K | Buy |
335,217
+138,768
| +71% | +$264K | ﹤0.01% | 2609 |
|
|
2016
Q3 | $330K | Buy |
196,449
+86,605
| +79% | +$106K | ﹤0.01% | 3006 |
|
|
2016
Q2 | $115K | Sell |
109,844
-41,805
| -28% | -$40.4K | ﹤0.01% | 3238 |
|
|
2016
Q1 | $132K | Sell |
151,649
-25,497
| -14% | -$24.7K | ﹤0.01% | 3251 |
|
|
2015
Q4 | $214K | Buy |
177,146
+106,723
| +152% | +$149K | ﹤0.01% | 3529 |
|
|
2015
Q3 | $120K | Sell |
70,423
-82,914
| -54% | -$163K | ﹤0.01% | 3590 |
|
|
2015
Q2 | $319K | Buy |
153,337
+18,828
| +14% | +$45.7K | ﹤0.01% | 3386 |
|
|
2015
Q1 | $365K | Buy |
134,509
+28,511
| +27% | +$72.3K | ﹤0.01% | 3222 |
|
|
2014
Q4 | $272K | Buy |
+105,998
| New | +$238K | ﹤0.01% | 3694 |
|
|
2013
Q4 | – | Sell |
-11,809
| Closed | -$48K | – | 4769 |
|
|
2013
Q3 | $48K | Buy |
+11,809
| New | +$51.6K | ﹤0.01% | 4235 |
|
Other funds holding ATRS
D.E. Shaw & Co's ATRS Position: Q2 2022 in Review
D.E. Shaw & Co sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 238,233 shares — an estimated $976K sold.
D.E. Shaw & Co first reported a position in ATRS in Q3 2013 and held it in 18 quarters. The position peaked at $976K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- D.E. Shaw & Co reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- D.E. Shaw & Co sold 238,233 Antares Pharma, Inc. shares in Q2 2022, an estimated $976K.
- D.E. Shaw & Co first reported a position in Antares Pharma, Inc. in Q3 2013 and held it in 18 quarters.
- D.E. Shaw & Co's Antares Pharma, Inc. position peaked at $976K in Q1 2022.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.